World Library  
Flag as Inappropriate
Email this Article

BTG plc

Article Id: WHEBN0040626308
Reproduction Date:

Title: BTG plc  
Author: World Heritage Encyclopedia
Language: English
Subject: Hikma Pharmaceuticals, Pharmaceutical industry in the United Kingdom, Genus plc, Pharmacists' Defence Association, Vectura Group
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

BTG plc

BTG plc
Public
Traded as LSE: BTG
Industry Healthcare
Founded 1991 as British Technology Group Ltd.
Headquarters London, United Kingdom
Key people
Garry Watts (Chairman of the board), Louise Makin (CEO), Rolf Soderstrom (CFO)
Products Development, manufacturing and commercialisation of specialty pharmaceuticals and interventional medicine in the areas of critical care, cancer and varicose veins. BTG also has a revenue stream from royalty payments on partnered products.
Revenue £290.5 million (2014)[1]
£62.3 million (2014)[1]
Profit £24.3 million (2014)[1]
Website www.btgplc.com

BTG plc is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.

It trades as BTG International Inc. in the United States and as BTG International Ltd. in the United Kingdom.[2] The latter name arose as the result of the British Technology Group Ltd changing its name on 27 May 1998.[3] BTG is a constituent of the FTSE 250 Index.

History

In 1948, the National Research Development Corporation was formed with the purpose of commercialising innovations that arose from public funded research.[4] This was complemented in November 1975 by the establishment of the National Enterprise Board to implement the then-Government's policy of moving public sector industry into commercial private enterprise.[5]

These two organisations were merged by the Government in 1981 to form a new, non-statutory body called the British Technology Group.[6] It acted principally to licence and commercialise the use of publicly funded developments. The Group was put onto a statutory footing in the British Technology Group Act 1991[7] with HM Treasury initially being the only shareholder. Subsequently, in March 1992, Cinven arranged a management buy-out from the Government. The company later floated on the London Stock Exchange in 1995.[4] Three years later, on 27 May 1998, the Group adopted its present name. It now focuses its work on developing and commercialising medical innovations.[4]

Since acquiring the commercialisation rights to magnetic resonance imaging (MRI) (under a revenue share scheme) in 1983, BTG has come to licence a large part of the world market in MRI, including licencees such as General Electric and Philips.[8]

BTG plc completed the acquisition of Protherics PLC in December 2008 and of Biocompatibles International plc in January 2011.[9]

Operations

BTG earns revenues from specialty pharmaceutical and interventional medicine product sales and on royalties from partnered products. The company has operations in Europe, North America and Australia.

See also

References

  1. ^ a b c
  2. ^
  3. ^
  4. ^ a b c Overview of BTG International's history
  5. ^
  6. ^ Abstract of Department of Trade and Industry report "Monitoring of British Technology Group"
  7. ^
  8. ^ Case study of BTG's MRI licensing
  9. ^

External links

  • BTG plc's website
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.